Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

CONy 2021 | The key role of genetics in the diagnosis and management of Alzheimer’s disease

Richard Pither, PhD, Cytox Ltd, Oxford, UK, discusses the future role of genetics in the diagnosis and clinical management of Alzheimer’s disease. Dr Pither argues that genetics already play an important role, which is likely to expand in the future. Advances in the field have led to an improved understanding of the genetic underpinning of the common late-onset form of Alzheimer’s disease. Therefore, the current debate is not whether genetics should be used but rather how to use them in the management of Alzheimer’s disease and drug development. This interview was conducted during the virtual 2021 World Congress on Controversies in Neurology (CONy) meeting.


Dr Pither is an employee of Cytox Ltd